Lisata Therapeutics, Inc.
LSTA
$2.50
-$0.03-1.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -17.26% | 8.20% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.55% | -1.71% | |||
| Operating Income | 16.74% | -18.15% | |||
| Income Before Tax | 18.06% | -23.34% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1.38% | -2.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.38% | -2.47% | |||
| EBIT | 16.74% | -18.15% | |||
| EBITDA | 16.88% | -18.26% | |||
| EPS Basic | 1.42% | -0.02% | |||
| Normalized Basic EPS | 18.08% | -15.36% | |||
| EPS Diluted | 1.42% | -0.02% | |||
| Normalized Diluted EPS | 18.08% | -15.36% | |||
| Average Basic Shares Outstanding | 0.03% | 2.47% | |||
| Average Diluted Shares Outstanding | 0.03% | 2.47% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||